NCT05880446 (PROCAR-BQ) is a NA clinical trial of Bowel symptoms & QoL assessment in Prostate Cancer, sponsored by Jules Bordet Institute.

Who is sponsoring NCT05880446?

NCT05880446 is sponsored by Jules Bordet Institute.

What drugs are being tested in NCT05880446?

Interventions in NCT05880446: Bowel symptoms & QoL assessment.

What condition does NCT05880446 study?

NCT05880446 studies Prostate Cancer, Radiotherapy Side Effect, Bowel Dysfunction, Quality of Life.

Is NCT05880446 still recruiting?

NCT05880446 is currently completed. Last updated 13 May 2024.

Last reviewed 2024-05-13 · How we verify

NCT05880446: PROCAR-BQ

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

PROstate CAncer Radiotherapy - Bowel Quality of Life (PROCAR-BQ)

Completed NA Last updated 13 May 2024

What this trial tests

NA trial testing Bowel symptoms & QoL assessment in Prostate Cancer in 41 participants. Completed in 29 March 2024.

Timeline

6 October 2023

Primary endpoint
29 March 2024

29 March 2024

Quick facts

Lead sponsor	Jules Bordet Institute
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	diagnostic
Enrollment	41
Start date	6 October 2023
Primary completion	29 March 2024
Estimated completion	29 March 2024
Sites	1 location across Belgium

Drugs / interventions tested

Bowel symptoms & QoL assessment

Conditions studied

Prostate Cancer — all drugs for Prostate Cancer →
Radiotherapy Side Effect — all drugs for Radiotherapy Side Effect →
Bowel Dysfunction — all drugs for Bowel Dysfunction →
Quality of Life — all drugs for Quality of Life →

Sponsor

Jules Bordet Institute

Who can join

Eligibility, male only, with Prostate Cancer or Radiotherapy Side Effect. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a prospective pilot study to evaluate the mean increase of bowel symptoms after pelvic radiotherapy (RT) in prostate cancer (PCa) patient using the validated \& newly translated EORTC-QLQ PRT20 module.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Exploration of Predictive Factors for Acute Radiotherapy-Induced Gastro-Intestinal Symptoms in Prostate Cancer Patients.
De Bruyn P, Klass M, Van Muylem A, Jullian N, et al · · 2025 · PMID 41463283 · DOI 10.3390/cancers17244035

Verify or expand the search:

Other recruiting trials for Prostate Cancer

Currently open trials in the same condition.

NCT06960798 — Characterizing the Genomic Landscape of Prostate Cancer in Native American Populations (NAT-Geno) · recruiting
NCT07237269 — Abi/Pred + ADT vs ADT in PSMA-Positive, Conventionally Node-Negative Prostate Cancer · Phase 2 · recruiting
NCT07234981 — PSMA-PET Guided De-escalation of Salvage Radiation Treatment in Recurrent Prostate Cancer · Phase 2 · recruiting
NCT07027124 — Neoadjuvant ADT + Darolutamide With Pembrolizumab, Followed by Adjuvant Pembrolizumab in Molecularly Stratified High-Ris · Phase 2 · recruiting
NCT07426094 — PRO-BOOST-N: Prostate-First Versus Combined Prostate and Nodal Dose Escalation in PSMA PET-Staged Node-Positive Prostate · Phase 2, PHASE3 · recruiting

Other Jules Bordet Institute trials

Trials by the same sponsor.

NCT07455331 — Flash Radiotherapy for Skin Cancer · Phase 2 · not yet recruiting
NCT07431346 — Prophylactic Intervention for Dysgeusia in Head and Neck Cancer Patients Following Radio(Chemo)Therapy · NA · not yet recruiting
NCT06925984 — Stereotactic Radiotherapy for Oligoprogressive ER+/HER- Metastatic Breast Cancer, a Prospective Phase 2 Study (Oligopro- · NA · recruiting
NCT06523634 — Salvage Stereotactic Body Radiotherapy of the Prostate Bed for Biochemical Recurrence After Radical Prostatectomy. · NA · recruiting
NCT06227338 — ICG-fluorescence Imaging for Intraoperative Breast Cancer Margins Evaluation: a Dose-timing Study · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05880446 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Jules Bordet Institute
Last refreshed: 13 May 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05880446.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing